Stock-Based Compensation - Stock Options and Significant Valuation Assumptions (Details) - Stock Options - USD ($)
$ / shares in Units, $ in Thousands |
|
|
12 Months Ended |
Oct. 29, 2014 |
Apr. 11, 2014 |
Apr. 01, 2017 |
Mar. 26, 2016 |
Mar. 28, 2015 |
| Assumptions used |
|
|
|
|
|
| Expected option term |
|
|
P5Y6M
|
P5Y6M
|
P5Y6M
|
| Expected volatility factor, minimum |
|
|
35.80%
|
33.30%
|
37.00%
|
| Expected volatility factor, maximum |
|
|
36.00%
|
36.70%
|
56.20%
|
| Risk-free interest rate, minimum |
|
|
|
1.30%
|
1.40%
|
| Risk-free interest rate, maximum |
|
|
|
1.80%
|
2.00%
|
| Risk-free interest rate |
|
|
1.40%
|
|
|
| Expected annual dividend yield |
|
|
0.00%
|
0.00%
|
0.00%
|
| Stock Options |
|
|
|
|
|
| Outstanding at the beginning of period |
|
|
2,447,133
|
|
|
| Granted |
|
|
560,892
|
|
|
| Exercised |
|
|
(210,177)
|
|
|
| Canceled, forfeited or expired |
|
|
(254,188)
|
|
|
| Outstanding at the end of period |
|
|
2,543,660
|
2,447,133
|
|
| Vested and expected to vest after end of period |
|
|
2,543,660
|
|
|
| Exercisable at end of period |
|
|
1,395,160
|
|
|
| Grant Date Weighted-Average Exercise Price |
|
|
|
|
|
| Outstanding at the beginning of period |
|
|
$ 9.87
|
|
|
| Granted |
|
|
7.38
|
|
|
| Exercised |
|
|
6.05
|
|
|
| Canceled, forfeited or expired |
|
|
13.27
|
|
|
| Outstanding at the end of period |
|
|
9.29
|
$ 9.87
|
|
| Vested and expected to vest at end of period |
|
|
9.29
|
|
|
| Exercisable at end of period |
|
|
$ 7.64
|
|
|
| Weighted Average Remaining Contractual Life |
|
|
|
|
|
| Weighted average remaining contractual life, awards outstanding |
|
|
5 years 10 months 24 days
|
|
|
| Weighted average remaining contractual life, awards vested and expected to vest |
|
|
5 years 10 months 24 days
|
|
|
| Weighted average remaining contractual life, awards exercisable |
|
|
5 years 4 months 24 days
|
|
|
| Aggregate Intrinsic Value |
|
|
|
|
|
| Aggregate intrinsic value, awards exercised |
|
|
$ 1,208
|
|
|
| Aggregate intrinsic value, awards outstanding |
|
|
6,475
|
|
|
| Aggregate intrinsic value, awards vested and expected to vest |
|
|
6,475
|
|
|
| Aggregate intrinsic value, awards exercisable |
|
|
$ 4,463
|
|
|
| Reduction to exercise price (in dollars per share) |
|
$ 2.00
|
|
|
|
| Number of options for which exercise price was lowered |
|
1,918,550
|
|
|
|
| 2014 Plan | CEO |
|
|
|
|
|
| Assumptions used |
|
|
|
|
|
| Stock price (in dollars per share) |
$ 16.00
|
|
|
|
|
| Exercise price (in dollars per share) |
$ 16.00
|
|
|
|
|
| Expected option term |
P6Y
|
|
|
|
|
| Expected volatility factor |
55.00%
|
|
|
|
|
| Risk-free interest rate |
1.80%
|
|
|
|
|
| Expected annual dividend yield |
0.00%
|
|
|
|
|
| Stock Options |
|
|
|
|
|
| Granted |
99,650
|
|
|
|
|